
Sean C. Barron
Examiner (ID: 726, Phone: (571)270-5111 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653 |
| Total Applications | 723 |
| Issued Applications | 324 |
| Pending Applications | 127 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19536965
[patent_doc_number] => 12129506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Microorganisms and methods for the production of fatty acids and fatty acid derived products
[patent_app_type] => utility
[patent_app_number] => 17/809750
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 51994
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809750 | Microorganisms and methods for the production of fatty acids and fatty acid derived products | Jun 28, 2022 | Issued |
Array
(
[id] => 18449610
[patent_doc_number] => 20230190886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 17/848998
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848998 | ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING | Jun 23, 2022 | Abandoned |
Array
(
[id] => 18483665
[patent_doc_number] => 20230210966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/838127
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838127 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF | Jun 9, 2022 | Pending |
Array
(
[id] => 18483665
[patent_doc_number] => 20230210966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/838127
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838127 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF | Jun 9, 2022 | Pending |
Array
(
[id] => 18483665
[patent_doc_number] => 20230210966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/838127
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838127 | EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES WITH POTASSIUM CHANNEL AGONISTS AND THERAPEUTIC USES THEREOF | Jun 9, 2022 | Pending |
Array
(
[id] => 18210404
[patent_doc_number] => 20230056666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES
[patent_app_type] => utility
[patent_app_number] => 17/836922
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836922 | BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES | Jun 8, 2022 | Abandoned |
Array
(
[id] => 18210404
[patent_doc_number] => 20230056666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES
[patent_app_type] => utility
[patent_app_number] => 17/836922
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836922 | BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES | Jun 8, 2022 | Abandoned |
Array
(
[id] => 18210404
[patent_doc_number] => 20230056666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES
[patent_app_type] => utility
[patent_app_number] => 17/836922
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836922
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836922 | BIOREACTOR PARADIGM FOR THE PRODUCTION OF SECONDARY EXTRA-PARTICLE HYPHAL MATRICES | Jun 8, 2022 | Abandoned |
Array
(
[id] => 18340369
[patent_doc_number] => 20230132318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF IMPLANTING ENGINEERED TISSUE CONSTRUCTS
[patent_app_type] => utility
[patent_app_number] => 17/827128
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28484
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17827128
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/827128 | METHODS OF IMPLANTING ENGINEERED TISSUE CONSTRUCTS | May 26, 2022 | Abandoned |
Array
(
[id] => 17805825
[patent_doc_number] => 20220257660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => RECOMBINANT erIL-15 NK CELLS
[patent_app_type] => utility
[patent_app_number] => 17/732190
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17732190
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/732190 | RECOMBINANT erIL-15 NK CELLS | Apr 27, 2022 | Pending |
Array
(
[id] => 17988957
[patent_doc_number] => 20220354994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/727293
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727293 | IN SITU EXPANSION OF ENGINEERED DEVICES FOR REGENERATION | Apr 21, 2022 | Abandoned |
Array
(
[id] => 18312775
[patent_doc_number] => 20230116675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => LIQUID-BASED CELL PRESERVATION SOLUTION AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/726498
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726498 | LIQUID-BASED CELL PRESERVATION SOLUTION AND METHOD FOR PREPARING SAME | Apr 20, 2022 | Abandoned |
Array
(
[id] => 18312775
[patent_doc_number] => 20230116675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => LIQUID-BASED CELL PRESERVATION SOLUTION AND METHOD FOR PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/726498
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726498
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726498 | LIQUID-BASED CELL PRESERVATION SOLUTION AND METHOD FOR PREPARING SAME | Apr 20, 2022 | Abandoned |
Array
(
[id] => 17670876
[patent_doc_number] => 20220184043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH AMD3100 AND TACROLIMUS
[patent_app_type] => utility
[patent_app_number] => 17/684959
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684959 | METHODS OF TREATING INFLAMMATORY BOWEL DISEASE WITH AMD3100 AND TACROLIMUS | Mar 1, 2022 | Pending |
Array
(
[id] => 17774992
[patent_doc_number] => 20220241341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => METHODS TO REBALANCE THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS
[patent_app_type] => utility
[patent_app_number] => 17/677202
[patent_app_country] => US
[patent_app_date] => 2022-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/677202 | METHODS TO REBALANCE THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS | Feb 21, 2022 | Pending |
Array
(
[id] => 17642312
[patent_doc_number] => 20220170050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => METHANOTHERMOBACTER THERMAUTOTROPHICUS STRAIN AND VARIANTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/673455
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -125
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673455 | None | Feb 15, 2022 | Issued |
Array
(
[id] => 17790548
[patent_doc_number] => 20220249639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHODS OF TUMOR VACCINATION
[patent_app_type] => utility
[patent_app_number] => 17/580919
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580919 | Methods of tumor vaccination | Jan 20, 2022 | Issued |
Array
(
[id] => 17688198
[patent_doc_number] => 20220195490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHOD FOR RECOVERING MICROBIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/578802
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17578802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/578802 | METHOD FOR RECOVERING MICROBIAL CELLS | Jan 18, 2022 | Abandoned |
Array
(
[id] => 18901494
[patent_doc_number] => 20240016979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/255307
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255307
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255307 | AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR | Dec 21, 2021 | Pending |
Array
(
[id] => 18901494
[patent_doc_number] => 20240016979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR
[patent_app_type] => utility
[patent_app_number] => 18/255307
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255307
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/255307 | AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR | Dec 21, 2021 | Pending |